Immune-related cancer toxicities: what pharmacists need to know

In this episode, Caitlin Killen, assistant clinical editor, and Alex Clabburn, senior editor, enlist the help of two experts to explore what the rise in immunotherapy treatment means for the ongoing care of cancer patients. Many thanks to Dharmisha Chauhan, lead genomic clinical pharmacist for North Thames Genomic Medicine Service Alliance and specialist oncology pharmacist at The Royal Marsden NHS Foundation Trust, and Stuart Evans, cancer pharmacist at South West Wales Cancer Centre at Singleton Hospital and Swansea Bay University Health Board for their expertise. For a list of related immunotherapy resources and links to the research mentioned in the podcast visit the PJ website: https://pharmaceutical-journal.com/article/feature/immune-related-cancer-toxicities-what-pharmacists-need-to-know This episode was produced by Geoff Marsh and was supported by Merck.